CAS: 1219097-41-2
| Marque | Informations sur le produit | Degré de pureté | Gamme de prix | Livraison estimée |
|---|---|---|---|---|
 | Gatifloxacin Related Compound E (1-Cyclopropyl-6-fluoro-8-methoxy-7-(2-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid monohydrochloride) REF : 45-1288452CAS : 1219097-41-2 | - - - | 1.441,00 € | lun 10 Mar 25 |
 | Gatifloxacin related compound E REF : 3D-UYB09741CAS : 1219097-41-2 | Min. 95% | À demander | mar 22 Avr 25 |
Gatifloxacin Related Compound E (1-Cyclopropyl-6-fluoro-8-methoxy-7-(2-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid monohydrochloride)
CAS :1219097-41-2
Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, …
Formule :
C19H22FN3O4·HCl
Couleur et forme :
Solid
Masse moléculaire :
411.13611
Ref: 45-1288452
| 15mg | 1.441,00 € |
Livraison estimée en/au États-Unis, le lundi 10 mars 2025
Gatifloxacin related compound E
CAS :1219097-41-2
Gatifloxacin related compound E (GFX-E) is a hypoglycemic agent that inhibits the growth of bacteria …
Formule :
C19H22FN3O4·HCl
Degré de pureté :
Min. 95%
Masse moléculaire :
411.86 g/mol
Ref: 3D-UYB09741
| 10mg | 1.071,00 € | ||
| 25mg | 1.746,00 € | ||
| 50mg | 2.793,00 € |
Livraison estimée en/au États-Unis, le mardi 22 avril 2025
